{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:16:26Z","timestamp":1793308586449,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-026-00609-x","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:46:33Z","timestamp":1781088393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effects of resveratrol on glycemic indices and lipid profile in patients with type 2 diabetes: an umbrella review and meta-analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Faezeh","family":"Ghalichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Molani-Gol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Tejareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laleh","family":"Payahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"3","key":"609_CR1","first-page":"461","volume":"13","author":"L Payahoo","year":"2014","unstructured":"Payahoo L, Ostadrahimi A, Mobasseri M, Khajebishak Y, Jafarabadi MA, Mahdavi AB. Sepide Mahluji, Anethum graveolens L. supplementation has anti-inflammatory effect in type 2 diabetic patients. Indian J Tradit Knowl. 2014;13(3):461\u20135.","journal-title":"Indian J Tradit Knowl"},{"key":"609_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157:107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"609_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1322072","volume":"12","author":"N Hazar","year":"2024","unstructured":"Hazar N, Jokar M, Namavari N, Hosseini S, Rahmanian V. An updated systematic review and meta-analysis of the prevalence of type 2 diabetes in Iran, 1996\u20132023. Front Public Health. 2024;12:1322072.","journal-title":"Front Public Health"},{"key":"609_CR4","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus, Diabetes care. 33;(Supplement_1):2010;S62\u20139.","DOI":"10.2337\/dc10-S062"},{"issue":"7086","key":"609_CR5","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944\u20138.","journal-title":"Nature"},{"issue":"suppl_1","key":"609_CR6","doi-asserted-by":"publisher","first-page":"s5","DOI":"10.2337\/diacare.26.2007.S5","volume":"26","author":"E.C.o.t. Diagnosis, C.o.D. Mellitus","year":"2003","unstructured":"E.C.o.t. Diagnosis, C.o.D. Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl_1):s5\u201320.","journal-title":"Diabetes Care"},{"key":"609_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:1\u201319.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"609_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2337\/dc13-2114","volume":"37","author":"CL Martin","year":"2014","unstructured":"Martin CL, Albers JW, Pop-Busui R, D.E.r. Group. Neuropathy and related findings in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2014;37(1):31\u20138.","journal-title":"Diabetes Care"},{"issue":"3","key":"609_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","volume":"87","author":"P Zhang","year":"2010","unstructured":"Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293\u2013301.","journal-title":"Diabetes Res Clin Pract"},{"key":"609_CR10","unstructured":"Atlas D, International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015, Eur Respir J 2006;27:188\u2013207."},{"issue":"1","key":"609_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1503\/cmaj.081713","volume":"180","author":"LL Lipscombe","year":"2009","unstructured":"Lipscombe LL. Thiazolidinediones: do harms outweigh benefits? CMAJ. 2009;180(1):16\u20137.","journal-title":"CMAJ"},{"issue":"5","key":"609_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cmet.2011.02.015","volume":"13","author":"Y Endo","year":"2011","unstructured":"Endo Y, Suzuki M, Yamada H, Horita S, Kunimi M, Yamazaki O, Shirai A, Nakamura M, Iso-O N, Li Y. Thiazolidinediones enhance sodium-coupled bicarbonate absorption from renal proximal tubules via PPAR\u03b3-dependent nongenomic signaling. Cell Metabol. 2011;13(5):550\u201361.","journal-title":"Cell Metabol"},{"issue":"1","key":"609_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1108\/NFS-02-2019-0056","volume":"50","author":"H Tutunchi","year":"2020","unstructured":"Tutunchi H, Asghari Jafarabadi M, Hoojeghani S, Tabrizi S, Farrin N, Payahoo L, Ostadrahimi A. General and abdominal obesity is related to socioeconomic status and food choices: a cross-sectional study. Nutr Food Sci. 2020;50(1):61\u201373.","journal-title":"Nutr Food Sci"},{"issue":"2","key":"609_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1503\/cmaj.1031414","volume":"172","author":"AY Cheng","year":"2005","unstructured":"Cheng AY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172(2):213\u201326.","journal-title":"CMAJ"},{"issue":"1","key":"609_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/bja\/aer120","volume":"107","author":"G Nicholson","year":"2011","unstructured":"Nicholson G, Hall G. Diabetes mellitus: new drugs for a new epidemic. Br J Anaesth. 2011;107(1):65\u201373.","journal-title":"Br J Anaesth"},{"issue":"2","key":"609_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1124\/pr.110.003319","volume":"64","author":"E Verspohl","year":"2012","unstructured":"Verspohl E. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev. 2012;64(2):188\u2013237.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"609_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12011-016-0764-6","volume":"175","author":"A Ostadrahimi","year":"2017","unstructured":"Ostadrahimi A, Payahoo L, Somi MH, Khajebishak Y. The association between urinary cadmium levels and dietary habits with risk of gastrointestinal cancer in Tabriz, Northwest of Iran. Biol Trace Elem Res. 2017;175(1):72\u20138.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"609_CR18","first-page":"11","volume":"3","author":"M Pandey","year":"2010","unstructured":"Pandey M, Verma RK, Saraf SA. Nutraceuticals: new era of medicine and health. Asian J Pharm Clin Res. 2010;3(1):11\u20135.","journal-title":"Asian J Pharm Clin Res"},{"key":"609_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-023-03604-4","author":"S-A Ghalichi F","year":"2023","unstructured":"Ghalichi F S-A, Kafil B, Faghfouri AH, Rajabi Jourshari M, Akbari Naserkiadeh A, Ostadrahimi A. Insulin receptor substrates regulation and clinical responses following vanadium-enriched yeast supplementation in obese type 2 diabetic patients: a randomized, double-blind, placebo-controlled clinical trial. Biol Trace Elem Res. 2023;201:5169\u20135182. https:\/\/doi.org\/10.1007\/s12011-023-03604-4","journal-title":"Biol Trace Elem Res"},{"key":"609_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2022.126955","volume":"26","author":"OAF Ghalichi","year":"2022","unstructured":"Ghalichi OAF, Saghafi-Asl M. Vanadium and diabetic dyslipidemia: a systematic review of animal studies. J Trace Elem Med Biol. 2022;26:126955.","journal-title":"J Trace Elem Med Biol"},{"issue":"16","key":"609_CR21","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1080\/10408398.2021.1875980","volume":"62","author":"FM Delpino","year":"2022","unstructured":"Delpino FM, Figueiredo LM. Resveratrol supplementation and type 2 diabetes: a systematic review and meta-analysis. Critical reviews in food science and nutrition. 2022;62(16):4465\u201380.","journal-title":"Critical reviews in food science and nutrition"},{"issue":"6","key":"609_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1. Cell. 2006;127(6):1109\u201322.","journal-title":"Cell"},{"issue":"3","key":"609_CR23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2337\/db09-0482","volume":"59","author":"J-H Um","year":"2010","unstructured":"Um J-H, Park S-J, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMP-activated protein kinase\u2013deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010;59(3):554\u201363.","journal-title":"Diabetes"},{"issue":"11","key":"609_CR24","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1021\/jf0112973","volume":"50","author":"J Burns","year":"2002","unstructured":"Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002;50(11):3337\u201340.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"609_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ptr.5737","volume":"31","author":"A Zare Javid","year":"2017","unstructured":"Zare Javid A, Hormoznejad R, Yousefimanesh HA, Zakerkish M, Haghighi-zadeh MH, Dehghan P, et al. The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytotherapy research. 2017;31(1):108\u201314.","journal-title":"Phytotherapy research"},{"issue":"3","key":"609_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"S-J Park","year":"2012","unstructured":"Park S-J, Ahmad F, Philp A, Baar K, Williams T, Luo H, et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell. 2012;148(3):421\u201333.","journal-title":"Cell"},{"issue":"20","key":"609_CR27","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4161\/cc.6.20.4815","volume":"6","author":"V Cucciolla","year":"2007","unstructured":"Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Ragione FD. Resveratrol: from basic science to the clinic. Cell cycle. 2007;6(20):2495\u2013510.","journal-title":"Cell cycle"},{"issue":"5","key":"609_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1248\/bpb.31.897","volume":"31","author":"C Silan","year":"2008","unstructured":"Silan C. The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull. 2008;31(5):897\u2013902.","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"609_CR29","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jvs.2005.08.014","volume":"42","author":"B Poussier","year":"2005","unstructured":"Poussier B, Cordova AC, Becquemin J-P, Sumpio BE. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg. 2005;42(6):1190-1190. e14.","journal-title":"J Vasc Surg"},{"issue":"13","key":"609_CR30","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/01.CIR.0000029925.18593.5C","volume":"106","author":"T Wallerath","year":"2002","unstructured":"Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, F\u00f6rstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation. 2002;106(13):1652\u20138.","journal-title":"Circulation"},{"issue":"3","key":"609_CR31","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1017\/S0007114511000316","volume":"106","author":"P Brasny\u00f3","year":"2011","unstructured":"Brasny\u00f3 P, Moln\u00e1r GA, Moh\u00e1s M, Mark\u00f3 L, Laczy B, Cseh J, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106(3):383\u20139.","journal-title":"Br J Nutr"},{"issue":"1","key":"609_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9734738","volume":"2022","author":"W Gu","year":"2022","unstructured":"Gu W, Geng J, Zhao H, Li X, Song G. Effects of resveratrol on metabolic indicators in patients with type 2 diabetes: a systematic review and meta-analysis. Int J Clin Pract. 2022;2022(1):9734738.","journal-title":"Int J Clin Pract"},{"issue":"2\u20133","key":"609_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cbi.2009.09.003","volume":"182","author":"M R\u00fcweler","year":"2009","unstructured":"R\u00fcweler M, G\u00fclden M, Maser E, Murias M, Seibert H. Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro. Chem Biol Interact. 2009;182(2\u20133):128\u201335.","journal-title":"Chem Biol Interact"},{"issue":"13","key":"609_CR34","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.lfs.2006.12.036","volume":"80","author":"A Kumar","year":"2007","unstructured":"Kumar A, Kaundal RK, Iyer S, Sharma SS. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 2007;80(13):1236\u201344.","journal-title":"Life Sci"},{"issue":"6","key":"609_CR35","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3945\/ajcn.113.082024","volume":"99","author":"K Liu","year":"2014","unstructured":"Liu K, Zhou R, Wang B, Mi M-T. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2014;99(6):1510\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"609_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1530\/JOE-14-0335","volume":"223","author":"M Rouse","year":"2014","unstructured":"Rouse M, Youn\u00e8s A, Egan JM. Resveratrol and curcumin enhance pancreatic \u03b2-cell function by inhibiting phosphodiesterase activity. J Endocrinol. 2014;223(2):107.","journal-title":"J Endocrinol"},{"issue":"6","key":"609_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/advances\/nmaa075","volume":"11","author":"V Gowd","year":"2020","unstructured":"Gowd V, Kang Q, Wang Q, Wang Q, Chen F, Cheng K-W. Resveratrol: evidence for its nephroprotective effect in diabetic nephropathy. Adv Nutr. 2020;11(6):1555\u201368.","journal-title":"Adv Nutr"},{"issue":"4","key":"609_CR38","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.4238\/2011.November.29.7","volume":"10","author":"A Yar","year":"2011","unstructured":"Yar A, Menevse S, Alp E. The effects of resveratrol on cyclooxygenase-1 and-2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genet Mol Res. 2011;10(4):2962\u201375.","journal-title":"Genet Mol Res"},{"issue":"12","key":"609_CR39","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1210\/en.2009-0528","volume":"150","author":"G Ramadori","year":"2009","unstructured":"Ramadori G, Gautron L, Fujikawa T, Vianna CR, Elmquist JK, Coppari R. Central administration of resveratrol improves diet-induced diabetes. Endocrinology. 2009;150(12):5326\u201333.","journal-title":"Endocrinology"},{"issue":"17","key":"609_CR40","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1080\/10408398.2017.1349076","volume":"58","author":"X-F Guo","year":"2018","unstructured":"Guo X-F, Li J-M, Tang J, Li D. Effects of resveratrol supplementation on risk factors of non-communicable diseases: a meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2018;58(17):3016\u201329.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"609_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.phrs.2017.12.033","volume":"129","author":"F Haghighatdoost","year":"2018","unstructured":"Haghighatdoost F, Hariri M. Effect of resveratrol on lipid profile: an updated systematic review and meta-analysis on randomized clinical trials. Pharmacol Res. 2018;129:141\u201350.","journal-title":"Pharmacol Res"},{"issue":"5","key":"609_CR42","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1210\/jc.2016-2160","volume":"102","author":"TN Kj\u00e6r","year":"2017","unstructured":"Kj\u00e6r TN, Ornstrup MJ, Poulsen MM, St\u00f8dkilde-J\u00f8rgensen H, Jessen N, J\u00f8rgensen JOL, et al. No beneficial effects of resveratrol on the metabolic syndrome: a randomized placebo-controlled clinical trial. J Clin Endocrinol Metab. 2017;102(5):1642\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"609_CR43","doi-asserted-by":"crossref","unstructured":"Shea BCRBJ, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both, bmj 2017;358.","DOI":"10.1136\/bmj.j4008"},{"key":"609_CR44","volume":"2021","author":"T Zhang","year":"2021","unstructured":"Zhang T, He Q, Liu Y, Chen Z, Hu H. Efficacy and safety of resveratrol supplements on blood lipid and blood glucose control in patients with Type 2 Diabetes: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5644171.","journal-title":"Evid Based Complement Alternat Med"},{"key":"609_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.795980","volume":"13","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Wang Y, Han X, Fu S, Zhu C, Chen Q. Efficacy of resveratrol supplementation on glucose and lipid metabolism: a meta-analysis and systematic review. Front Physiol. 2022;13:795980.","journal-title":"Front Physiol"},{"key":"609_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12986-017-0217-z","volume":"14","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wu C, Qiu S, Yuan X, Li L. Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. Nutr Metab (Lond). 2017;14:60.","journal-title":"Nutr Metab (Lond)"},{"issue":"1","key":"609_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/oby.22348","volume":"27","author":"H Zhao","year":"2019","unstructured":"Zhao H, Song A, Zhang Y, Shu L, Song G, Ma H. Effect of resveratrol on blood lipid levels in patients with type 2 diabetes: a systematic review and meta-analysis. Obesity. 2019;27(1):94\u2013102.","journal-title":"Obesity"},{"key":"609_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10010069","author":"BI Garc\u00eda-Mart\u00ednez","year":"2021","unstructured":"Garc\u00eda-Mart\u00ednez BI, Ruiz-Ramos M, Pedraza-Chaverri J, Santiago-Osorio E, Mendoza-N\u00fa\u00f1ez VM. Hypoglycemic effect of resveratrol: a systematic review and meta-analysis. Antioxidants Basel. 2021;10:69\u201391. https:\/\/doi.org\/10.3390\/antiox10010069","journal-title":"Antioxidants Basel"},{"issue":"1","key":"609_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mnfr.201400173","volume":"59","author":"HA Hausenblas","year":"2015","unstructured":"Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus\u2013systematic review and meta-analysis. Mol Nutr Food Res. 2015;59(1):147\u201359.","journal-title":"Mol Nutr Food Res"},{"key":"609_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"issue":"5","key":"609_CR51","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","volume":"20","author":"HD Clark","year":"1999","unstructured":"Clark HD, Wells GA, Hu\u00ebt C, McAlister FA, Salmi LR, Fergusson D, et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials. 1999;20(5):448\u201352.","journal-title":"Control Clin Trials"},{"issue":"20","key":"609_CR52","first-page":"9117","volume":"23","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhao H, Dong L, Zhen Y, Xing H, Ma H, Song G. Resveratrol ameliorates high-fat diet-induced insulin resistance and fatty acid oxidation via ATM-AMPK axis in skeletal muscle. Eur Rev Med Pharmacol Sci. 2019;23(20):9117\u201325.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"609_CR53","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/jas\/skz057","volume":"97","author":"HZ Zhang","year":"2019","unstructured":"Zhang HZ, Chen DW, He J, Zheng P, Yu J, Mao XB, et al. Long-term dietary resveratrol supplementation decreased serum lipids levels, improved intramuscular fat content, and changed the expression of several lipid metabolism-related miRNAs and genes in growing-finishing pigs. J Anim Sci. 2019;97(4):1745\u201356.","journal-title":"J Anim Sci"},{"issue":"1","key":"609_CR54","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2010.05844.x","volume":"1215","author":"T Szkudelski","year":"2011","unstructured":"Szkudelski T, Szkudelska K. Anti-diabetic effects of resveratrol. Ann N Y Acad Sci. 2011;1215(1):34\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"609_CR55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1900\/RDS.2013.10.236","volume":"10","author":"NG Vallianou","year":"2014","unstructured":"Vallianou NG, Evangelopoulos A, Kazazis C. Resveratrol and diabetes. Rev Diabet Stud. 2014;10(4):236.","journal-title":"Rev Diabet Stud"},{"key":"609_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1208\/s12249-011-9584-3","volume":"12","author":"KA Ansari","year":"2011","unstructured":"Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech. 2011;12:279\u201386.","journal-title":"AAPS PharmSciTech"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00609-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-026-00609-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-026-00609-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T12:02:48Z","timestamp":1781092968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-026-00609-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":56,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s40199-026-00609-x","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}